Several arrested as protests erupt over planned US-backed Ebola isolation facility in Kenya

Author: dailypost.ngPublished on: June 9, 2026Country: Kenya

HealthWorld / InternationalCrime & Law

Several arrested as protests erupt over planned US-backed Ebola isolation facility in Kenya

Security operatives in Kenya arrested several demonstrators on Tuesday during renewed protests against the construction of a US-backed Ebola isolation facility. The arrests occurred as protests escalated. The planned facility has sparked significant controversy among local residents.

Stay informed with NewsBoulevard

Get the latest news summaries delivered to your inbox

Related News

Butembo records its first patient cured of Ebola

HealthDemocratic Republic of Congo

actualite.cd•8m ago

Butembo records its first patient cured of Ebola

Butembo, in eastern Democratic Republic of Congo, has recorded its first patient cured of Ebola. This recovery marks progress in the fight against the epidemic raging in the region. The patient was treated at a local treatment center and declared cured after negative tests. This hope comes as the Ebola epidemic in DRC has already caused 101 deaths out of 550 confirmed cases, with Ituri as the epicenter.

Goma-Nyiragongo: MSF sets up an Ebola treatment center in Munigi

HealthDemocratic Republic of the Congo

actualite.cd•8m ago

Goma-Nyiragongo: MSF sets up an Ebola treatment center in Munigi

Médecins Sans Frontières (MSF) has established an Ebola treatment center in Munigi, in the Goma-Nyiragongo area. This initiative aims to strengthen the response to the Ebola outbreak in the Democratic Republic of Congo. The center will manage suspected and confirmed patients, helping to curb the spread of the virus.

Cancers: What to Know About the Significant Advances at the American ASCO Congress – La Nouvelle Tribune

HealthUnited States

Florian Guénet•38m ago

Cancers: What to Know About the Significant Advances at the American ASCO Congress – La Nouvelle Tribune

The annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago in early June 2026 unveiled a promising new treatment for pancreatic cancer. The drug daraxonrasib targets the KRAS mutation and doubled the life expectancy of patients in clinical trials. Each year, 16,000 new cases are diagnosed in France with a fatality rate of 80 to 90%. Researchers remain cautious but consider this the most significant advance in decades.

Stay Updated with NewsBoulevard

Subscribe to our newsletter for the latest news summaries delivered to your inbox

Learn more